Search - tctmd.com

Displaying 21 - 40 of 55

Sort: Relevancy | Date

Presentation TCT 2024

Optimizing Outcomes: Contemporary Practices for Patient Management

Presenter: Navin Kapur

October 28, 2024

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

Impact of Microaxial Flow Pump on Central Hemodynamics and Use of Vasoactive Drugs During Intensive Care After Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Presenter: Nanna Louise Junker Udesen

October 27, 2024

Presentation TCT 2024

Microaxial Flow Pump Use and Renal Outcomes in Cardiogenic Shock: An Analysis of the DanGer Shock Trial

Presenter: Jacob Moeller

October 27, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Features

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

L.A. McKeown

September 25, 2024

News Daily News

Pandemic Burnout Survey Uncovers Work-Life Stressors Among Cardiology Staff

L.A. McKeown

September 19, 2024

News Daily News

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Caitlin E. Cox

August 28, 2024

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

Todd Neale

August 12, 2024

News Daily News

ChatGPT-Generated Echo Reports Help Explain Findings to Patients

Yael L. Maxwell

August 02, 2024

News Opinion Editor's Corner

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Michael O'Riordan

July 31, 2024

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Daily News

Undiagnosed Valvular Heart Disease Prevalent in Older Adults

Yael L. Maxwell

June 27, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

Presentation NY Valves 2024

SAVR After TAVR: A Dangerous Epidemic?

Presenter: Shinichi Fukuhara

June 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Conference News ESC Heart Failure 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Michael O'Riordan

May 13, 2024

News Conference News SCAI 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

L.A. McKeown

May 10, 2024

News Daily News

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

Todd Neale

May 09, 2024

Advertisement

Optimizing Outcomes: Contemporary Practices for Patient Management

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Impact of Microaxial Flow Pump on Central Hemodynamics and Use of Vasoactive Drugs During Intensive Care After Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Microaxial Flow Pump Use and Renal Outcomes in Cardiogenic Shock: An Analysis of the DanGer Shock Trial

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

Pandemic Burnout Survey Uncovers Work-Life Stressors Among Cardiology Staff

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

ChatGPT-Generated Echo Reports Help Explain Findings to Patients

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

TCTMD’s Top 10 Most Popular Stories for June 2024

Undiagnosed Valvular Heart Disease Prevalent in Older Adults

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

SAVR After TAVR: A Dangerous Epidemic?

TCTMD’s Top 10 Most Popular Stories for May 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content